Skip to main content
Retour
Watch Compare

Rallybio Corp

Qualité des données : 100%
RLYB
Nasdaq Manufacturing Chemicals
8,12 €
▼ 0,10 € (-1,22%)
Cap. Boursière: 42,95 M
Prix
8,12 €
Cap. Boursière
42,95 M
Fourchette du Jour
8,08 € — 8,28 €
Fourchette 52 Semaines
1,79 € — 11,49 €
Volume
30 155
Ouverture 8,16 €
Moyenne 50J / 200J
7,29 €
11,31% above
Moyenne 50J / 200J
5,31 €
52,93% above

Quick Summary

Points Clés

Negative free cash flow of -29,81 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)43,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-16,47%
Au-dessus de la moyenne du secteur (-51,02%)
ROIC-47,88%
Net Margin-1046,39%
Op. Margin-3853,61%

Sécurité

Debt / Equity
N/A
Current Ratio14,74
Interest CoverageN/A

Valorisation

PE (TTM)
-4,78
En dessous de la moyenne du secteur (-1,98)
P/B Ratio0,68
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -4,8 -2,0
P/B 0,7 5,1
ROE % -16,5 -51,0
Net Margin % -1046,4 -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 43,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 858 000,0 Net Income (TTM) -8,98 M
ROE -16,47% ROA -15,13%
Gross Margin N/A Operating Margin -3853,61%
Net Margin -1046,39% Free Cash Flow (TTM) -29,81 M
ROIC -47,88% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 14,74
Interest Coverage N/A Asset Turnover 0,01
Working Capital 62,11 M Tangible Book Value 63,03 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,78 Forward P/E N/A
P/B Ratio 0,68 P/S Ratio 50,06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -69,41%
Market Cap 42,95 M Enterprise Value 10,83 M
Per Share
EPS (Diluted TTM) -1,59 Revenue / Share 0,16
FCF / Share -5,64 OCF / Share -5,64
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 332,07%
SBC-Adj. FCF -36,38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 858 000,0 600 000,0 — — —
Net Income -8,98 M -57,78 M -74,56 M -66,65 M -47,01 M
EPS (Diluted) -1,59 -1,33 -1,84 -2,09 —
Gross Profit — — — — —
Operating Income -33,06 M -60,50 M -78,93 M -67,88 M -45,65 M
EBITDA — — — — —
R&D Expenses 19,60 M 41,51 M 53,54 M 40,69 M 26,91 M
SG&A Expenses — — — — —
D&A 92 000,0 131 000,0 150 000,0 167 000,0 109 000,0
Interest Expense — — — 0,0 10 000,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 62,26 M 68,11 M 115,62 M 180,44 M 182,19 M
Total Liabilities 4,31 M 6,45 M 9,44 M 11,12 M 6,58 M
Shareholders' Equity 57,96 M 61,65 M 106,18 M 169,32 M 175,60 M
Total Debt — — — — —
Cash & Equivalents 31,37 M 13,90 M 24,49 M 56,96 M 175,33 M
Current Assets 61,25 M 67,84 M 114,79 M 179,50 M 180,87 M
Current Liabilities 4,22 M 6,24 M 9,26 M 10,74 M 6,55 M